Digoxin use is associated with increased risk of stroke in patients with non-valvular atrial fibrillation--a nationwide population-based cohort study.
Division of Cardiology, Department of Medicine, China Medical University Hospital, Taichung, Taiwan; Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan.
Shih-Sheng
SS
Chang
Kuan-Cheng
KC
Chang
Yu-Chen
YC
Wang
Chih-Hsin
CH
Muo
Pei-Ying
PY
Pai
Chi-Bin
CB
Chang
Chi-Yuan
CY
Li
Fung-Chang
FC
Sung
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000097:blood; D001281:Atrial Fibrillation / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D015331:Cohort Studies; D004077:Digoxin / Q000009:adverse effects* / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance / Q000379:methods; D012307:Risk Factors; D020521:Stroke / Q000097:blood / Q000139:chemically induced* / Q000453:epidemiology
D000889:Anti-Arrhythmia Agents; D004077:Digoxin
Atrial fibrillation; Digoxin; Platelet activation; Stroke